Lu, X.; Xie, T.; Lan, H.; Fan, Y.; Yang, J.; Liao, Q.; Jin, Y.; Zhu, Y.; Zhang, J.; Li, D.;
et al. Kun-Ling Wan Formula Ameliorates Postmenopausal Osteoporosis and Adipose Accumulation by Suppressing mTOR Signaling in Mesenchymal Stem Cells. Pharmaceuticals 2026, 19, 719.
https://doi.org/10.3390/ph19050719
AMA Style
Lu X, Xie T, Lan H, Fan Y, Yang J, Liao Q, Jin Y, Zhu Y, Zhang J, Li D,
et al. Kun-Ling Wan Formula Ameliorates Postmenopausal Osteoporosis and Adipose Accumulation by Suppressing mTOR Signaling in Mesenchymal Stem Cells. Pharmaceuticals. 2026; 19(5):719.
https://doi.org/10.3390/ph19050719
Chicago/Turabian Style
Lu, Xiaoqing, Tingting Xie, He Lan, Yaqi Fan, Jie Yang, Qianzan Liao, Yuxin Jin, Yaoxuan Zhu, Jingxin Zhang, Dexin Li,
and et al. 2026. "Kun-Ling Wan Formula Ameliorates Postmenopausal Osteoporosis and Adipose Accumulation by Suppressing mTOR Signaling in Mesenchymal Stem Cells" Pharmaceuticals 19, no. 5: 719.
https://doi.org/10.3390/ph19050719
APA Style
Lu, X., Xie, T., Lan, H., Fan, Y., Yang, J., Liao, Q., Jin, Y., Zhu, Y., Zhang, J., Li, D., Pan, C., Li, Q., Sun, K., Huo, X., Yuwen, T., Han, J.-Y., & Li, Y.
(2026). Kun-Ling Wan Formula Ameliorates Postmenopausal Osteoporosis and Adipose Accumulation by Suppressing mTOR Signaling in Mesenchymal Stem Cells. Pharmaceuticals, 19(5), 719.
https://doi.org/10.3390/ph19050719